Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long-acting GLP-1 Analogue in Healthy Male Subjects and Male Subjects With Type 2 Diabetes

This study has been completed.
Information provided by (Responsible Party):
Novo Nordisk A/S Identifier:
First received: September 13, 2012
Last updated: February 23, 2017
Last verified: February 2017
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 8, 2013
  Primary Completion Date: April 8, 2013 (Final data collection date for primary outcome measure)